It is a decent result. The market has been pricing us for failure though, so I would say a "good" result given the market's incorrect assesment of us. Let's hope the share price respondsappropriatelyI don't want to speak too soon.
- Forums
- ASX - By Stock
- NEU
- Ann: DAYBUE (trofinetide) 2024 net sales US$348 million
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.94%
!
$16.80

Ann: DAYBUE (trofinetide) 2024 net sales US$348 million, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.80 |
Change
0.320(1.94%) |
Mkt cap ! $2.109B |
Open | High | Low | Value | Volume |
$16.65 | $16.90 | $16.33 | $3.834M | 228.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 57 | $16.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.82 | 551 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 306 | 16.790 |
7 | 803 | 16.780 |
7 | 1139 | 16.770 |
8 | 1587 | 16.760 |
7 | 1153 | 16.750 |
Price($) | Vol. | No. |
---|---|---|
16.800 | 1136 | 3 |
16.810 | 451 | 6 |
16.820 | 813 | 10 |
16.830 | 613 | 8 |
16.840 | 1172 | 9 |
Last trade - 14.37pm 29/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |